Search

everythinglearnresearchcommunity

for

Search:↓

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Targeting SOX proteins may improve cancer treatment by restoring immune function.

The mTOR signaling pathway might play a role in radiation dermatitis, but more research is needed.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Erlotinib can cause nonscarring hair loss and itchy skin.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Different scalp conditions can lead to hair loss or tumors, with treatments varying from creams to surgery; early detection is crucial.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Targeting EGFR may help reduce hair loss from chemotherapy.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

K10 may not prevent tumors as previously thought and might increase benign tumor risk.

The research suggests new treatments for skin cancer could target specific cell growth pathways.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive forestomach cancer.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Radiation therapy successfully treated an elderly man's skin cancer and pre-cancerous scalp lesions.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

Wnt and Notch pathways are crucial for repairing blood stem cells after damage.

There's an urgent need for better treatments for hair loss caused by radiation therapy.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Early intervention and tailored management can reduce skin side effects from cancer treatments.